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Acute Prostatitis 
Background 
1. Definition  
o Acute painful infection/ inflammation localized to prostate gland with 
duration of less than 3 months 
2. Prostatitis classification - 4 classes  
o Acute bacterial prostatitis 
o Chronic bacterial prostatitis 
o Chronic prostatitis / Chronic pelvic pain syndrome (inflammatory and non 
inflammatory) 
o Asymptomatic inflammatory prostatitis
1
 
3. General information  
o Least common of the 4 classes of prostatitis
1
 
o Bacterial prostatitis (chronic and acute) constitute less than 10% of all cases 
of prostatitis
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o Probably variant form of UTI with reflux of germs into prostatic tissue 
o Cost nationally for evaluation and diagnosis of prostatitis estimated at $84 
million
2
 
 
Pathophysiology 
1. Pathology of disease  
o Bacterial invasion of prostate  
 Aerobic gram negative common  
 E. coli in 60-80% of infections 
 C. trachomatis has been shown to be confirmed causes of 
prostatitis and prostatic abscess
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 Pseudomonas, klebsiella, proteus are less common gram 
negative bacterial sources
1
 
 Gram positive  
 Enterococci 5-10% 
o Proposed mechanisms of infection  
 Reflux of infected urine into prostatic tissue through the prostatic 
and ejaculatory ducts 
 Ascending urethral infection from urethral meatus occurring most 
often during sexual intercourse
1
 
2. Incidence, prevalence  
o Exact incidence and prevalence not completely known due to lack of 
definitive diagnostic test and clinician variance 
o By age 79, 10-30% of men will have had a diagnosis of prostatitis (acute or 
chronic) 
o Estimated 2 million annual visits for all subtypes of prostatitis (acute or 
chronic)
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o Most common urologic diagnosis for males aged 50 or younger and 3rd 
most common for males aged 50 or greater
4
 
o Affects men of all ages and frequently is diagnosed in conjunction with 
benign prostatic hypertrophy
5
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o Prostatitis diagnosis (all classes) made approximately 2-2.5 times more in 
patients aged 36-50 yo and 51-66 yo than in men aged >66 yo
4
 
o Diagnosis not related to race
4
 
3. Risk factors  
o Trauma, dehydration, sexual abstinence, indwelling catheter, intermittent 
catheter, anatomic anomaly 
4. Morbidity / mortality  
o Bacteremia/ sepsis, Epididymitis, Chronic bacterial prostatitis, prostatic 
abscess  
 
Diagnosis 
1. History  
o Spiking fevers, chills, malaise, myalgia, dysuria, rectal pain, pelvic pain, 
cloudy urine, dribbling, hesitancy, urinary retention, prostatitis history 
2. Physical exam  
o Fever 
o Edematous, tender, warm prostate on rectal exam  
o Prostatic massage and vigorous digital rectal examination is contraindicated 
as it may induce bacteremia (SOR:C) 
o Pre an post massage test (PPMT) as well as Stanley Meares Four Glass test 
used to help diagnose chronic bacterial prostatitis are both contraindicated 
in acute bacterial prostatitis (SOR:C)
1
  
3. Diagnostic testing  
o Urinalysis and urine culture  
 Pyuria, hematuria, bacteriuria, cloudy, malodorous 
 On urine culture  
 Positive growth is >100,000 colony forming units (CFU) of 
species of bacteria 
 Negative result is no bacterial growth
1
 
 Gram stain (to initiate therapy) and culture of urine 
o CBC  
 May show leukocytosis with left shift 
o Blood culture  
 If bacteremia suspected 
o PSA may be elevated for 4-6 weeks after infection 
o No definitive one diagnostic test (SOR:C)
1
  
 
Differential Diagnosis  
1. Cystitis 
2. Urethritis 
3. Pyelonephritis 
4. Malignancy 
5. Urolithiasis 
6. Foreign body 
7. Acute urinary retention 
8. Trauma 
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Therapeutics 
1. Antibiotics  
o Most common bacteria involved include E. coli, klebsiella, proteus and 
pseudomonas
1
 
o Oral therapy - 1st line, usually given for 4-6 weeks  
 TMP-SMX or cotrimoxazole (1 double strength tablet q12hr) or 
fluoroquinolone (ciprofloxacin 500 mg q12hr)
1
 
 Ampicillin 500 mg q6hr or amoxicillin 500 mg q8hr for enterococci
1
 
 Cephalexin 500 mg q6hr or dicloxacillin 500 mg q6hr for Staph. or 
Strep (SOR:C)
1
  
 Consider doxycycline if Chlamydia suspected (SOR:C)
1
 
o Parenteral therapy: given if unable to tolerate oral antibiotics or if patient 
appears systemically ill and may require hospitalization  
 Ceftriaxone IV with aminoglycoside 
 Cefuroxime IV with aminoglycoside 
 Cefotaxime IV with aminoglycoside  
 Patient to be switched to oral antibiotics if responding well, 
prescribed for at least 4 weeks (SOR:C)
5
  
2. Alpha-adrenoreceptor blockers  
o Use in case of urinary retention 
o If residual volume is less than 100 mL, add alpha adrenoreceptor blocker, if 
greater than 100 mL, will need to consider catheterization (SOR:C)
5
  
3. NSAIDs for pain and inflammation 
4. Antipyretics, stool softeners, hydration as needed for comfort 
5. Transurethral catheterization or instrumentation contraindicated - obtain urology 
consult if catheter needed - usually done suprapubically 
 
Follow-Up 
1. Return to office  
o In <7 days if symptoms worsen despite therapy 
o In 7 days  
 Repeat urinalysis and culture 
 If culture remains positive, change antibiotic therapy 
2. Refer to specialist if  
o No response to treatment  
 Consider hospitalization 
 Suspect abscess - transrectal ultrasonography, CT scan or MRI 
useful in diagnosis of prostatic abscess
1
 
o Complications suspected 
3. Admit to hospital if  
o Unable to tolerate PO intake 
o Signs of toxicity/sepsis  
 Hypotension 
 Altered mental status 
 Tachycardia 
 Dehydration 
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Prognosis 
1. Curable condition  
2. Recurrence, prostatic abscesses, and chronic prostatitis can develop 
 
Prevention 
1. Chronic suppressive antibiotic therapy for recurrent infections may be helpful 
 
Patient Education 
1. http://familydoctor.org/online/famdocen/home/men/prostate/581.html 
2. http://www.mayoclinic.com/health/prostatitis/ds00341  
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